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Characterization of tonsillar IL10 
secreting B cells and their role in 
the pathophysiology of tonsillar 
hypertrophy
Lindybeth Sarmiento Varon1, Javier De Rosa1, Andrés Machicote1, Luis Ariel Billordo1, Plácida 
Baz1, Pablo Mariano Fernández1,2, Isabel Kaimen Maciel3, Andrés Blanco4 & Eloísa I. Arana1,2
The comprehension of unconventional immune functions of tonsillar B cells, their role in tolerance 
induction and protective immune responses, is crucial to unveil the dynamic interactions of the upper 
aero digestive tract with polymicrobial commensal flora and pathogens, in health and disease. Here, 
we describe the kinetics of IL10 intracellular expression and compare it with that of cytokines known 
to be produced by tonsillar B cells. Additionally, we detected a relevant proportion of IL17-expressing 
tonsillar B cells, which has not previously been reported. We immunophenotyped tonsillar IL10-
expressing B cells (B10) and observed IL10 production in activated B cells at every developmental stage. 
Finally, we identified a relationship between decreased B10 percentages, increased proportion of the 
germinal centre (GC) population and hypertrophied tonsils (HT). Our findings provide greater insight 
into the role of B10 in GC reactions and characterized their involvement in the pathogenesis of tonsillar 
dysfunction.
Tonsils are the first sites where microbial and environmental antigens (Ags) entering through the upper aero 
digestive tract, are managed in the human body. Suitably located at the entrance of the pharynx to grant immu-
nologic protection, tonsils are continually exposed to dietary and airborne Ags. While lymph nodes depend on 
antigenic delivery through afferent lymphatics, tonsils have Ag-retaining crypts that increase their surface and 
enable the direct transport of the Ags deposited there, a feature that favours Ag presentation to lymphoid cells on 
the interior. These lymphoid cells are predominantly B cells (55% ± 15% of all tonsillar lymphocytes, depending 
on age). B cell receptor (BCR) engagement by Ags followed by cognate T follicular cell help (Tfh) drives the pro-
liferation of Ag-specific naive B cells in germinal centres (GCs). GCs are microenvironments within secondary 
lymphoid tissues (i.e., tonsils) that are critical for memory B cell and plasma cell generation1. Therefore, the 
tonsils are sites of increased expansion of B cell diversity and memory2. However, tonsillectomy is indicated for 
patients with a history of recurrent or chronic tonsillitis (RT) or for those with obstructive symptoms from tonsil-
lar hypertrophy (HT, no history of recurrent infections in the case of the samples in the present, unless indicated 
otherwise)3. The pathogenesis of these conditions remains largely unknown. Thus, human tonsils are unique 
inductive immune sites for B cell responses, provided that these organs operate properly.
Such responses are not restricted to antibody production and Ag presentation. B cell-derived cytokines are 
crucial for multiple aspects of immunity4, and new B cell subpopulations have consequently been identified. For 
example, a subset of B cells that produce the anti-inflammatory cytokine IL10, designated Bregs by Mizoguchi5, 
has been reported in mice and humans. In humans, multiple studies have shown that these cells are either numer-
ically or functionally deficient in several diseases6–11 and are also related to renal transplant tolerance12. More 
recently, B cells have also been demonstrated as a source of the pro-inflammatory cytokine IL17 -which was 
initially thought to be exclusively secreted by Th17 cells- in a murine model13 and in human PBMCs14.
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Tonsillar immune actions (anti- and pro-inflammatory) must be tightly regulated to balance the protection 
against virulent germs and the tolerance to harmless flora and innocuous Ags in the oropharynx. We proposed 
that because tonsils are B cell organs, the B10 population plays a role in such regulation. Despite the relevance of 
the issue in light of the importance gained by the mucosal route of vaccine administration, tonsillar B10 has not 
yet been fully characterized.
In the present study, we determined the phenotype of tonsillar B10, analysed the kinetics of IL10 intracellular 
expression and compared these results with those of other cytokines produced by tonsillar B cells. Notably, this 
study is the first to report a relevant proportion of IL17-expressing tonsillar B cells. Finally, we discuss the physi-
ological relevance of B10 in vivo, as samples donated from HT patients presented a lower proportion of B10 and 
a higher fraction of GC than samples donated from RT patients.
Results and Discussion
Characterization of IL10 production by B cells from human tonsils. Co-treatment with CpG and 
CD40L is a potent method of inducing IL10 production by circulating B cells, peaking at 72 hours hs post stimu-
lation15. As tonsillar B cells express high levels of TLR916, we used this approach to examine their production of 
IL10 at the single cell level using FACS. IL2 and IL4 were also added to the culture, as they promote the survival 
of all B cell subsets17. The cells that were already dead prior to permeabilization were excluded from the analysis 
based on their forward- and side-light scatter properties (P1, Fig. 1a), as we confirmed that the fixation procedure 
utilized appropriately preserved the cell morphology. Such scatter-based assay for distinguishing the viability of 
untransformed human B cells showed consistency with the results obtained from FITC-annexin staining18, 19. We 
previously confirmed the results using dead cell staining and showed that dead cell discrimination by forward/
side scatter presented excellent consistency with the results obtained using 7 amino-actinomycin D (7AAD) 
staining specifically for tonsillar B cells17. We observed a substantial production of IL10 (Fig. 1a). Tonsillar and 
circulating B cell subsets exhibit differences with respect to the kinetics of activation17; therefore, we replicated 
the assay at earlier time points. We observed a trend similar to that reported for circulating B cells6, 7, 20. While the 
proportion of tonsillar B10 steadily increased between 16 and 72 hs in all cases (Fig. 1b and e), the proportion of 
B10 detected at the different time points varied between donors and the cause of each surgery, an issue that will be 
addressed in the following sections. As a control for the appropriate stimulation of tonsillar B cells, we also meas-
ured IL6 and IL8 expression, as these are cytokines with faster release kinetics than IL1016. We confirmed that 
tonsillar B cell cultures readily produced other cytokines at early time points at which IL10 was barely detected 
(Fig. 1c, d and e). We concluded that comparable signals induce circulating B10 and tonsillar B10 to express IL10 
in vitro in a similar fashion in terms of kinetics and overall percentage.
Notably, unlike IL10, in some cases, significant levels of IL6 and IL8 could be detected at the single cell level 
without CpG/CD40L stimulation (at 0 hs, ~8.5% and ~7.5%, respectively, for the patient shown in Fig. 1c and d), 
confirming our previous reports in relation to the capacity of tonsillar B cells to promptly produce good amounts 
of such cytokines on a per cell basis, reflecting their adaptation to a strong and immediate inflammatory response 
on site17. At 16 hs post stimulation, ~17% of the tonsillar B cell population had become IL6-secreting cells, ~8% 
had become IL8-secreting cells, and ~2.5% represented the B10 population. At the following time point, 32 hs 
post stimulation, more than one-third of B cells in culture produced IL6, whereas ~12% of B cells exhibited intra-
cellular IL8, and IL10 could be detected in ~4% of B cells. Finally, at 72 hs post stimulation, approximately ~2% of 
the B cells in culture expressed either IL6 or IL8. Thus, in terms of the relative kinetics of production, these find-
ings were consistent with those of Gantner F. et al.15 using an alternative method to measure cytokines and further 
confirmed the ability of B cells to secrete pro and anti-inflammatory cytokines, as recently reviewed by Shen 
and Fillatreau4. With regard to the percentage of IL6- and IL8-secreting cells at different time points, the results 
varied across individuals; therefore, we showed the contour plots of a single patient and graph lines plotting the 
results of 5 different patients for the cytokine kinetics. Further work into recruiting more patients is required to 
perform meaningful statistics and accurately elucidate putative associations between the proportions and levels 
of pro-inflammatory cytokine expression and causes of surgery, as described below for IL10.
Importantly, we also observed that tonsillar B cells produced considerable amounts of IL17 (Fig. 2). IL17 
secretion by T cells (Th17) has been implicated in defence against extracellular pathogens and the pathogenesis 
of inflammatory diseases. As tonsillectomy generally indicates the chronic inflammation of tonsils due to RT 
and/or HT, our observation seems logical. While Th17 cells have been the subject of multiple studies, reports on 
the secretion of IL17 by B cells are scarce13, 14. Hence, these results complement the reports of previous studies, 
extending such capacity to B cell rankings in the human mucosal immunology system. When we analysed the 
kinetics, IL17 secretion from tonsillar B cells peaked upon 32 hs of CpG and CD40L stimulation.
It was not feasible to detect whether B10 co-expressed any of these pro inflammatory cytokines, as intracellu-
lar cytokine levels at the 72 hs time point were quite low for the whole culture. Moreover, as evidenced in Figs 1 
and 2a, this late time point was particularly affected by the down-modulation of surface CD20 in response to dif-
ferent stimuli, and this effect has been extensively described previously21, 22. As the present study is the first report 
on tonsillar IL17-expressing B cells and their progress in time, we seek to improve such determination at 72 hs 
by excluding CD3+ cells as likely contaminants when CD20 expression is lost (Fig. 2b). Finally, we supplemented 
cultures with just IL2 and IL4, which prolong cell survival with minimal stimulation, thus circumventing CD20 
downregulation and confirming IL17 expression by tonsillar B cells under those conditions (Fig. 2c).
Collectively, these results demonstrated that despite disease-associated changes, such as RT and HT, B cells 
from those damaged tonsils preserve their immune competence to secrete a number of cytokines. Considering 
that B cells comprise the majority of tonsillar lymphocytes17, an understanding of the relative levels of the dif-
ferent cytokine expressing B cell subsets and their association with tonsillar pathology and oral microbiome 
certainly requires further investigation. Importantly, a comprehensive picture of the effect of B cell cytokines on 
nearby cells and their microenvironment may inform new therapies for paediatric patients.
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Figure 1. Cytokine intracellular expression by tonsillar B cells. (a) B cell cytoplasmic IL10 expression by 2 
tonsil donors. Tonsil 1 was from a patient with RT (representative of this group) and 2, representative from 
patients with HT. TMC were cultured for 72 hs on CpG+CD40L+IL2+IL4. The cells were subsequently stained 
for surface CD20 and intracellular IL10. To detect IL10, the samples shown in the right panels were stimulated 
with PMA/ionomycin/Brefeldin A for the last 5 hs. Control sets (left panels) did not receive such treatment. 
P1 denotes the percentage of living cells determined using FSC-SSC dot plot profiles within the singlets gate. 
P2 denotes the percentage of B10 among CD20+ B cells. Total CD20+ B cells are indicated within the large red 
gate representing 100% of B cells. The data from one experiment representative of 12 independent experiments 
performed with different individuals are presented. (b), (c) and (d) Kinetics of cytoplasmic IL10, IL6 and IL8 
expression by tonsillar B cells, respectively. The cells were stained for surface CD20 and intracellular IL10, IL6 
or IL8. The percentages designate cytokine-producing B cell frequencies among CD20+ B cells. Total CD20+ B 
cells are indicated within the large red gate representing 100% of B cells. CD20+ IL10+ (b) CD20+ IL6+ (c) and 
CD20+ IL8+ (d) detected at the different time points of culture, indicated in the top panel, are specified with 
the small red gate. TMC were cultured and stimulated as in (a). The data from one experiment representative 
of 5 independent experiments performed with different individuals are presented. (e) Line graphs plotting the 
results of 5 different individuals for IL10, IL6, and IL8 kinetics, respectively.
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Phenotype of IL-10-competent tonsillar B cells. The better understood and most studied regulatory 
mechanism of B cells is mediated by IL10; therefore circulating human B10 had been exhaustively phenotyped6, 7, 19. 
Considering the critical role that tissue environment imprints on the different immune cellular subsets, we char-
acterized tonsillar B10. We performed a multiparametric FACS assay on tonsillar B cells to analyse the expression 
of numerous cell surface markers previously associated with an IL10-secreting profile in B cells isolated from 
PBMCs. Compared with their IL10– B cell counterparts, tonsillar B10 expressed statistically significant higher 
levels of CD24, CD27, CD38, CD39, PDL1, CD25, CD1d, CD5, and CD21, consistent with the observations 
previously published for circulating B10 under similar conditions (Fig. 3a) and extensively reviewed in ref. 23. 
However, B10 did not significantly differ from IL10– B cells in terms of the expression of CD73, CD62L and IgD 
(Fig. 3a), the latter presenting bimodal expression for both populations in all cases.
Figure 2. Cytoplasmic IL17 expression by tonsillar B cells. (a) Kinetics of cytoplasmic IL17 expression. TMC 
were cultured for the time points indicated at the top of each panel, on CpG+CD40L+IL2+IL4. To detect 
IL17, the cells were stimulated with PMA/ionomycin/Brefeldin A for the last 5 hs and subsequently stained 
for surface CD20 and intracellular IL17. Upper panels: P1 denotes percentage of living cells determined using 
FSC-SSC dot plot profiles within the singlets gate (determination of singlets gate not shown). Lower panels: 
dot plots showing IL17 and CD20 expression from TMC gated on the P1 population. Percentages designate 
frequencies of the populations in each quadrant. Data from one experiment representative of 5 independent 
experiments performed with different individuals are presented. (b) TMC were cultured for 72 hs on 
CpG+CD40L+IL2+IL4 and PMA/ionomycin/Brefeldin A for the last 5 hs. The cells were subsequently stained 
for surface CD20 using a different fluorophore than used in (a), CD3 and intracellular IL17. P1 indicates living 
cells determined using FSC-SSC dot plot profiles within the singlets gate and P2 indicates the CD3- CD20+/
down cells. CD20+/downL17+ cells are shown in red. (c) TMC were cultured for 72 hs on IL2+IL4 and PMA/
ionomycin/Brefeldin A for 5 hs. The cells were subsequently stained for surface CD20, CD3 and intracellular 
IL17. P1 indicates living cells determined using FSC-SSC dot plot profiles within the singlets gate and P2 
indicates CD20+ cells. CD20+IL17+ cells are shown in red.
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Figure 3. Presence of IL10 secreting B cells at every developmental stage after activation. (a) Upper panel, 
representative flow cytometry contour plots for CD20+ IL10+ (red) vs. CD20+ IL10- (light blue) cells. Lower 
panels, extended phenotyping of IL10+ (red histogram) vs. IL10 - B cells (light blue histogram). TMC were 
cultured in the presence of CpG+CD40L+IL2+IL4 for 72 hs and subsequently stimulated with PMA/
ionomycin/Brefeldin A for the last 5 hs. The data from one experiment representative of 10 independent 
experiments performed with different individuals are presented. A graph showing the MFI fold increment 
(median of fluorescence of B10/median of fluorescence of IL10– B cells) for each independent experiment for 
the respective molecule is shown below each representative overlay of histograms. p results correspond to a 
one-sample t-test, reflecting a null hypothesis that there were no differences in MFI between B10 and IL10– B 
cells (expected ratio of 1 for the test). (b) Dot plot depicting B10 cells (in red) within the classification of human 
tonsillar B cell subsets based on the expression of IgD/CD38 as in20 the graph obtained using the backgating 
option. TMC were cultured in the presence of CpG+CD40L+IL2+IL4 for 16 hs and subsequently stimulated 
with PMA/ionomycin/Brefeldin A for the last 5 hs. The data from a patient with a significant level of IL10 
expression at 16 hs are shown as big dots to highlight the scattered B10 cell pattern on the CD20+ population, 
which appears as a solid grey cloud reflecting the amount and size of the dots. (a) and (b) All results correspond 
to events within singlets and viable gates.
www.nature.com/scientificreports/
6SCIENtIfIC REPoRTS | 7:_####_ | DOI:10.1038/s41598-017-09689-x
The Bm1-5 classification system24 is generally used to identify the multiple B cell subsets present in ton-
sils. In terms of development, every stage of B cell differentiation is represented in secondary lymphoid tissues, 
such as tonsils, and these stages can be cytometrically identified as Bm1: IgD+CD38− (virgin naïve cells); Bm2: 
IgD+CD38+ (activated naïve cells not distinguishable from unswitched memory B cells with this classification); 
Bm2′: IgD+CD38++ (pre-GC cells indistinguishable from transitional B cells); Bm3 and Bm4: IgD−CD38++(same 
phenotype for GC cells and plasmablasts); and eBM5 and Bm5: IgD−CD38+/− (memory cells). To further evaluate 
where the B10 subset would fall under such classification scheme, we stimulated the cells for a shorter period 
of time (16 hs), as such brief stimulation is adequate for B10 to produce IL10 without inducing changes in the 
overall phenotype of the CD20+ culture. We detected B10 within the Bm2, Bm2′, Bm3, Bm4 eBm5 and Bm5 
subsets (Fig. 3b). The present study is not the first to report that B10 are diffusely scattered throughout the B cell 
lineage. According to previous reports, B10 could be present within the IgM memory10, GC-derived plasma-
blast11, and immature transitional6, 10 compartments. In fact, whether the immature transitional compartment 
effectively contains B10 remains controversial25. As previously indicated by Iwata and colleagues7, we confirmed 
(data not shown) that B10 do not express CD10 at the high levels required for classification as immature precur-
sors. Through the CD10 staining, we could distinguish between pre-GC cells and transitional B cells. Therefore, 
we can ascertain that tonsillar B10 are pre-GC cells, indicating prior Ag stimulation. In any case, this plethora 
of phenotypes can only be plausible if B10 cells experience the entire differentiation programme once activated, 
secreting IL10 at every developmental stage, suggesting that these cells are pre-destined for this function, i.e., 
these cells comprise a separate lineage.
Hypertrophied tonsils with intensively active germinal centres are characterized by a reduced 
B10 population compared with tonsils excised as a result of recurrent tonsillitis. As previously 
mentioned, the samples donated for the present study were derived from several diseases: RT, HT (no history of 
recurrent infections), and eventually, HT combined with RT (Table 1). The differences in the pathologies that 
led to surgery were useful to assess the physiological relevance of tonsillar B10. We only received 2 samples from 
patients with HT combined with RT; thus, a relevant statistical analysis with that group was not feasible, and 
we showed the results from these patients but limited the discussion to the groups that included a majority of 
patients, granting statistical relevance to the observations. For the patients listed in Table 1, we scored the per-
centages of B10 following the gating strategy depicted in Supplementary Fig. S1. As we used cell shape to distin-
guish dead/live cells as opposed to using a more reliable fixable viability dye, we cannot rule out contaminating 
dead cells in the P1 gate, which could non-specifically bind anti-IL10. The isotype control (see Supplementary 
Fig. S1) evidenced that such fraction accounted for less than 0.5% of the cells. Interestingly, HT tonsils accounted 
for samples with a significantly lower percentage of B10 cells compared to those from RT (Fig. 4a, p < 0.005) 
and presented a significantly higher proportion of the GC population (Bm3 and Bm4, Fig. 4b; p < 0.005 Fig. 4c) 
than those from children with RT. Such comparative increment of the GC percentage was not accompanied by a 
proportional growth of the memory B cell population in those HT samples. In contrast, these samples displayed 
a significantly lower percentage of the eBm5 subset than RT samples (Fig. 4b; p < 0.005 Fig. 4c), indicative of a 
putative blockade between the GC and memory B cell stages on HT patients. This finding is consistent with the 
results of a previous report26, in which the authors compared histological cross sections of the surgical samples 
from HT and RT patients. Notably, they found that the number of GCs is the only histopathological criterion that 
can be used to differentiate the samples from the two groups. In this context, Achouret al.27 recently demonstrated 
a role for tonsillar B10 in controlling the functions of Tfh cells. The results of the present study extended these 
findings, uncovering a correlation in vivo, as lower the proportion of B10 implied the deficient suppression of Tfh 
functions and a consequent failure to repress the GC reactions, as observed in the HT samples. Moreover, using 
FACS and immunohistochemistry, Yamashita and colleagues showed increased the number of Tfh cells in HT 
tonsillar samples compared with RT samples28. Taken together, these findings also support the notion that B10 
are indeed a committed functional lineage, as a blockage in the differentiation of these cells affects the proportion 
of the entire subset.
As it is long established that regulatory T cells (Tregs) are essential to tolerance29, 30, there have been studies 
characterizing tonsillar Tregs31, 32. However, tonsils are essentially B cell organs, which turn them in an excellent 
and novel model to study inflammatory and regulatory immune mechanisms from a human B cell perspective. 
In conclusion, we characterized IL10 secretion by tonsillar B cells, and the results contributed to a comprehensive 
picture of the cytokine-secreting B cell population in tonsils. The results suggest a role for the B10 population as a 
distinct lineage in the pathophysiology of HT. We provided evidence that defective B10 compartment indicates an 







Number of patients 5 5 2
Gender
Female 3 4 1
Male 2 1 1
Age in years (mean {range}) 4.2 {2–6} 13.4 {3–30} Female: 16 Male: 6
Other observations Male also suffered asthma
Table 1. Data of tonsils’ donors.
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the accurate role of the B10 population. This study advances our understanding of the immune functions of the 
tonsils, a subject that has gained momentum not only in light of interests in the nasal route for vaccine adminis-
tration to stimulate both mucosal and systemic immunity but also considering the prevalence of tonsillar diseases 
in childhood.
Figure 4. Physiological relevance of IL10-secreting B cells in tonsils. (a) The data show the mean %B10 ± S.D 
pooled from the independent experiments performed with tonsils from 12 different individuals grouped 
according the cause of surgery (RT, n = 5; HT, n = 5; HT+RT, n = 2; see Table 1). The proportion of B10 was 
determined using FACS, and TMC were stained for surface CD20, CD3 and intracellular IL10 after culture for 
72 hs in the presence of CpG+CD40L+IL2+IL4, followed by stimulationwith PMA/ionomycin/Brefeldin A 
for the last 5 hs. (b) Dot plot depicting the percentage of the tonsillar B cell subsets for the 3 groups of patients 
(a selected individual for RT; HT; HT+RT). Fresh TMC were stained for CD20, IgD, and CD38 for the patients 
detailed in 3a. Arrows and percentages indicate frequencies of GC and early memory B cell populations. (c) The 
data show the mean percentage of the frequencies of GC and early memory ± S.D pooled from independent 
experiments performed with tonsils from the same 12 individuals detailed in 3a. Statistical analysis of the results 
in 3a and 3c was performed using unpaired Student’s t test**p < 0.005.
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Methods
Isolation of cells. Primary human mononuclear cells were isolated from tonsils obtained from patients 
undergoing tonsillectomy. The total number of independent samples used for the different experiments 
accounted for N = 30. In the legend of each figure, we specified the number of patient samples used per experi-
ment. Tonsillar mononuclear cells (TMC) were prepared in the following manner. Briefly, tonsils were collected 
in phosphate-buffered saline (PBS) containing 50 μg ml−1 amphotericin B (Richet, Buenos Aires, Argentina). 
The tissues were chopped using a scalpel in complete medium and passed through a 70-μm pore cell strainer 
(Falcon, San Jose, CA, USA). TMC were purified using density gradient centrifugation with Ficoll-Hypaque (GE 
Healthcare, Little Chalfont, UK). The viability of primary cells, determined using trypan blue exclusion, was 
greater than 99% in all preparations. Informed consent was obtained from subjects prior to the study. The insti-
tutional ethics committee (Clinical Hospital, School of Medicine, Buenos Aires and Institute of Otolaringology 
Arauz, Buenos Aires) approved the collection and use of clinical materials, conformed to the provisions of the 
Declaration of Helsinki (as revised in Edinburgh 2000). Therefore, all methods were performed in accordance 
with the relevant guidelines and regulations. Informed consent was obtained from all participants and/or their 
legal guardian/s. All experiments were performed with freshly isolated cells.
Cell culture. Primary human B cells were cultured in IMDM medium (Life Technologies, Carlsbad, CA, 
USA) containing 10% heat-inactivated foetal calf serum, 2mM L-glutamine, 100 U/ml penicillin, 100 μg/ml strep-
tomycin, 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid buffer (HEPES), 1 mM sodium pyruvate 
and 50 μM 2-mercaptoethanol (all from Invitrogen, Carlsbad, CA, USA). Human IL2 (20 ng/ml; R&D Systems, 
Minneapolis, MN, USA) and human IL4 (20 ng/ml; R&D) were immediately added as supplements prior to ini-
tiating the experiments. Where indicated, human recombinant hCD40L (250 ng/ml; R&D Systems) and 25 μM 
CpG-ODN 2006 (InvivoGen, San Diego, CA, USA) were used. The cells were cultured at 1 × 106 cells/ml in either 
24-well (1 ml) or 48-well culture plates (0.5 ml).
Antibodies and flow cytometry. Fluorochrome-conjugated mAbs specific for human CD1d (clone 
CD1d42), CD3 (clone SK7), CD20(clone L27), IgD(clone IA6-2), CD38 (clone HIT2), CD24 (clone ML5), CD39 
(clone TU66), PDL-1 (clone MIH1), CD27 (clones M-T271 and Miltenyi clone LG.3A10), CD25 (clone M-A251), 
CD21 (clone B-ly4), CD5 (clone UCHT2), CD73 (clone AD2), CD62L (clone DREG-56), IL10 (clone JES3-9D7), 
IL6 (clone 8C9), IL8 (clone IT7F8), and IL17 (clone SCPL1382) and isotype control mAbs were purchased from 
BD Biosciences (San Jose, CA, USA), Biolegend (San Diego, CA, USA), Miltenyi (San Diego, CA, USA) and 
Immunotools (Friesoythe, Germany). For surface staining, TMC were incubated with excess mAb in PBS/1% 
BSA on ice for 40 min and washed in the same buffer. To evaluate the cytokines using intracellular staining, 
surface-stained cells were incubated with Cytofix/Cytoperm (BD PharMingen, San Jose, CA, USA) for 20 min 
in the dark and washed with Perm/Wash solution (BD PharMingen). Following permeabilization, the cells were 
stained with the respective anti-cytokine mAb. The cells were acquired using FACS Aria II (BD Biosciences) and 
analysed using FlowJo software (Treestar, Ashland, OR, USA). Single-stained controls were used to set compen-
sation parameters. Fluorescence minus one and isotype-matched Ab controls were used to set analysis gates. 
Apoptotic and viable cells were distinguished based on differences in forward and side scatter, all results corre-
spond to events within singlets and viable gates.
Statistical analyses. The results were analysed using GraphPad Prism 5.0 software. The statistical analysis 
of the results was performed using the unpaired t test, and a p value of <0.05 was considered significant unless 
otherwise indicated.
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